Broken String Biosciences (“Broken String”), a leader in advancing gene editing safety, today opened its Catalyst Early Access Program (EAP) for developers of gene-edited therapies that allow for the ...
BOSTON & CAMBRIDGE, England, August 05, 2025--(BUSINESS WIRE)--Broken String Biosciences ("Broken String"), a leader in advancing gene editing safety, today announced its formal re-engagement as a ...
Eurostar grant supports application of BioLizard’s AI expertise to Broken String’s INDUCE-seq® platform Resulting technology, called SafeGuide, will enable faster, more cost-effective development of ...
- Research published in Molecular Cell used INDUCE-seq to identify DNA topology as an important regulator of CRISPR targeting specificity - Peer-reviewed data demonstrates the sensitivity of ...
Broken String Biosciences (“Broken String”), a genomics company building a technology platform to drive the development of cell and gene therapies that are safer by design, today announced that its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results